HIV clinical trials

Explore recruiting hiv clinical trials.

Recruiting hiv studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

HIV trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Optimizing reversal of HIV latency with combination therapy (pyrimethamine, lenalidomide, panobinostat)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3b, multicenter, single-arm, open-label study evaluating the efficacy, safety, and tolerability of switching to DTG/3TC single tablet regimen administered once daily from a bictegravir/emtricitabine/tenofovir alafenamide single tablet regimen in people living with HIV of at least 50 years of age who are virologically suppressed

Belgium, Italy, Portugal, Austria, Spain, Germany +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of early switching to dolutegravir/lamivudine (DTG/3TC) from INSTI-based three-drug regimens in HIV-1-infected adults previously naïve who achieve virological suppression

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Curing HIV: proof of concept randomized clinical trial with Pyrimethamine, Lenalidomide, TOpiramate (PLUTO)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase II clinical trial investigating the effect of topiramate on the reactivation of the HIV-1 reservoir in people living with HIV on antiretroviral therapy

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

An Operationally Seamless Phase 2/3, Randomized, Active -Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination With GS-4182 Versus Biktarvy in Virologically Suppressed People With HIV-1

France, Germany, Poland, Sweden, Spain, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

HIV trials by city

HIV in Toronto HIV in Vancouver HIV in Montreal HIV in Calgary HIV in Edmonton HIV in Ottawa HIV in Winnipeg HIV in Quebec City HIV in Hamilton HIV in Kitchener HIV in London HIV in Halifax HIV in New York HIV in Los Angeles HIV in Chicago HIV in Houston

Other conditions

Bladder cancer Kidney cancer Liver cancer Glioblastoma Head and neck cancer Cervical cancer Endometrial cancer Gastric cancer Age-related macular degeneration Diabetic retinopathy Glaucoma Dry eye disease Hepatitis B Hepatitis C COVID-19 Influenza RSV Sickle cell disease Anemia Hemophilia Thalassemia Chronic pain Low back pain Smoking cessation